Respinova
Israel
11-50 employees
Established in 2008
Company description
See translation
Respinova has developed the PulseHaler, a noninvasive technology that aims to treat the core pathophysiology of COPD, small airways disease. COPD affects over 350 million people worldwide and is the third leading killer of all diseases. The Pulsehaler...
{{industry.name}}
{{pas.productName}}
HS code: {{pas.hsCode | limitTo: 23}}
HS code: {{pas.hsCode | limitTo: 23}}
Show more
Commercial information
Affiliations:
Start-Up Nation Central
This information is provided by Start-Up Nation Finder
Click here to see more
People in this company (1)
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us